Clinical importance of estrogen receptor beta isoforms in breast cancer

Valerie Speirs, Andrew R Green, Thomas A Hughes, Ian O Ellis, Philippa T K Saunders, Abeer M Shaaban

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)5825; author reply 5825-6
JournalJournal of Clinical Oncology
Volume26
Issue number35
DOIs
Publication statusPublished - 10 Dec 2008

Keywords

  • Biomarkers, Tumor
  • Breast Neoplasms
  • Drug Resistance, Neoplasm
  • Estrogen Receptor Modulators
  • Estrogen Receptor beta
  • Female
  • Humans
  • Immunohistochemistry
  • Predictive Value of Tests
  • Protein Isoforms
  • Reproducibility of Results
  • Treatment Outcome
  • Comment
  • Letter

Cite this

Speirs, V., Green, A. R., Hughes, T. A., Ellis, I. O., Saunders, P. T. K., & Shaaban, A. M. (2008). Clinical importance of estrogen receptor beta isoforms in breast cancer. Journal of Clinical Oncology, 26(35), 5825; author reply 5825-6. https://doi.org/10.1200/JCO.2008.19.5909